WallStSmart

Live Ventures Inc (LIVE)vsSanofi ADR (SNY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Sanofi ADR generates 10470% more annual revenue ($46.72B vs $441.98M). SNY leads profitability with a 16.7% profit margin vs 5.0%. LIVE trades at a lower P/E of 2.7x. SNY earns a higher WallStSmart Score of 49/100 (D+).

LIVE

Hold

44

out of 100

Grade: D

Growth: 4.0Profit: 5.5Value: 8.3Quality: 7.5
Piotroski: 5/9Altman Z: 2.02

SNY

Hold

49

out of 100

Grade: D+

Growth: 4.7Profit: 6.0Value: 4.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LIVEUndervalued (+39.6%)

Margin of Safety

+39.6%

Fair Value

$32.30

Current Price

$13.51

$18.79 discount

UndervaluedFair: $32.30Overvalued
SNYSignificantly Overvalued (-89.7%)

Margin of Safety

-89.7%

Fair Value

$24.79

Current Price

$46.03

$21.24 premium

UndervaluedFair: $24.79Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LIVE3 strengths · Avg: 9.7/10
P/E RatioValuation
2.7x10/10

Attractively priced relative to earnings

Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Return on EquityProfitability
26.3%9/10

Every $100 of equity generates 26 in profit

SNY3 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

Market CapQuality
$109.03B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.59B8/10

Generating 1.6B in free cash flow

Areas to Watch

LIVE4 concerns · Avg: 3.0/10
Market CapQuality
$39.93M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
5.0%3/10

5.0% margin — thin

Operating MarginProfitability
3.2%3/10

Operating margin of 3.2%

Debt/EquityHealth
1.213/10

Elevated debt levels

SNY3 concerns · Avg: 3.0/10
EPS GrowthGrowth
2.4%4/10

2.4% earnings growth

Return on EquityProfitability
6.7%3/10

ROE of 6.7% — below average capital efficiency

PEG RatioValuation
4.322/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : LIVE

The strongest argument for LIVE centers on P/E Ratio, Price/Book, Return on Equity.

Bull Case : SNY

The strongest argument for SNY centers on Price/Book, Market Cap, Free Cash Flow. Profitability is solid with margins at 16.7% and operating margin at 14.3%.

Bear Case : LIVE

The primary concerns for LIVE are Market Cap, Profit Margin, Operating Margin.

Bear Case : SNY

The primary concerns for SNY are EPS Growth, Return on Equity, PEG Ratio.

Key Dynamics to Monitor

LIVE profiles as a value stock while SNY is a mature play — different risk/reward profiles.

LIVE carries more volatility with a beta of 1.11 — expect wider price swings.

SNY is growing revenue faster at 6.9% — sustainability is the question.

SNY generates stronger free cash flow (1.6B), providing more financial flexibility.

Bottom Line

SNY scores higher overall (49/100 vs 44/100), backed by strong 16.7% margins. LIVE offers better value entry with a 39.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Live Ventures Inc

CONSUMER CYCLICAL · HOME IMPROVEMENT RETAIL · USA

Live Ventures Incorporated is engaged in flooring manufacturing, steel fabrication and retail businesses in the United States. The company is headquartered in Las Vegas, Nevada.

Visit Website →

Sanofi ADR

HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA

Sanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.

Want to dig deeper into these stocks?